Name : CDKN2D Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN5479551501
| Long name | CDKN2D Primary Polyclonal Antibody |
| Also known as | CDKN2D PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | CDKN2D |
| Specificity | This is a highly specific antibody against CDKN2D |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human CDKN2D/p19 INK4d |
| Gene ID number | 1032 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | Jul 2008], The abundance of the transcript of this gene was found to oscillate in a cell-cycle dependent manner with the lowest expression at mid G1 and a maximal expression during S phase, The negative regulation of the cell cycle involved in this protein was shown to participate in repressing neuronal proliferation, This protein has been shown to form a stable complex with CDK4 or CDK6, Two alternatively spliced variants of this gene, [provided by RefSeq, and prevent the activation of the CDK kinases, as well as spermatogenesis, have been reported, thus function as a cell growth regulator that controls cell cycle G1 progression, which encode an identical protein, The protein encoded by this gene is a member of the INK4 family of cyclin-dependent kinase inhibitors |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | CDKN2D, CDN2D_HUMAN, Cyclin dependent kinase inhibitor 2D, Cyclin-dependent kinase 4 inhibitor D, Cyclin-dependent kinase inhibitor 2D p19, INK4D, Nur77 associating protein, Similar to cyclin-dependent kinase inhibitor 2D, cell cycle inhibitor, inhibitor of cyclin-dependent kinase 4d, inhibits CDK4, p19, p19-INK4D, p19INK4d, CDK inhibitor p19INK4d |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | CDKN2D |
| Short name | CDKN2D Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | inhibits cyclin-dependent kinase 4) (Antibody to), cyclin-dependent kinase inhibitor 2D (p19 |
| Alternative technique | antibodies |
| Alternative to gene target | CDKN2D and IDBG-27803 and ENSG00000129355 and 1032, CDKN2D and IDBG-643316 and ENSBTAG00000010731 and 510244, Cdkn2d and IDBG-738755 and ENSMUSG00000096472 and 12581, INK4D and p19 and p19-INK4D, inhibits CDK4), nuclei, protein kinase binding, this GO :0000079 and regulation of cyclin-dependent protein serine/threonine kinase activity and biological process this GO :0000082 and G1/S transition of mitotic cell cycle and biological process this GO :0000278 and mitotic cell cycle and biological process this GO :0000731 and DNA synthesis involved in DNA repair and biological process this GO :0004861 and cyclin-dependent protein serine/threonine kinase inhibitor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0007050 and cell cycle arrest and biological process this GO :0007605 and sensory perception of sound and biological process this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0009411 and response to UV and biological process this GO :0019901 and protein kinase binding and molecular function this GO :0030308 and negative regulation of cell growth and biological process this GO :0032526 and response to retinoic acid and biological process this GO :0033280 and response to vitamin D and biological process this GO :0042326 and negative regulation of phosphorylation and biological process this GO :0043154 and negative regulation of cysteine-type endopeptidase activity involved in apoptotic process and biological process this GO :0048102 and autophagic cell death and biological process this GO :0071901 and negative regulation of protein serine/threonine kinase activity and biological process this GO :1902230 and negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage and biological process, this GO :0004861: cyclin-dependent protein serine/threonine kinase inhibitor activity, this GO :0004861: cyclin-dependent protein serine/threonine kinase inhibitor activity and also this GO :0005515: protein binding and also this GO :0019901: protein kinase binding, this GO :0005515: protein binding, this GO :0019901: protein kinase binding, cyclin-dependent kinase inhibitor 2D (p19 |
| Identity | 1790 |
| Gene | CDKN2D |
| Long gene name | cyclin dependent kinase inhibitor 2D |
| Synonyms gene name | cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
| Synonyms | INK4D p19 |
| Locus | 19p13, 2 |
| Discovery year | 1995-07-06 |
| Entrez gene record | 1032 |
| Pubmed identfication | 8575754 |
| RefSeq identity | NM_079421 |
| Classification | Ankyrin repeat domain containing |
| Havana BLAST/BLAT | OTTHUMG00000180583 |